Integer Holdings (NYSE: ITGR) announced today that Payman Khales has taken over the corner office at the medtech contract manufacturing giant.
Plano, Texas–based Integer first announced the transition in April, with Joseph Dziedzic retiring after eight years as CEO. Dziedzic will continue to serve as an adviser through March 31, 2026.
Khales joined Integer in 2018 as president of its Cardio & Vascular business, According to the company, he led a successful market- and customer-focused strategy, doubling sales in seven years and driving above-market growth, while further improving service levels and profitability. Most recently, he’s been COO, overseeing both of Integer’s business units and its global operations.
“It is a privilege to step into the role of CEO at Integer,” Khales said in a news release. “I am energized by the opportunities ahead as we continue to advance our strategy. Together with our talented associates, we will create value by innovating, collaborating with our customers, and delivering life-changing medical technologies to patients around the world. I am grateful to Joe for his mentorship and support, and I look forward to leading Integer.”
Before Integer, Mr. Khales held senior leadership roles at CECO Environmental Corp. and Ingersoll Rand Co. He earned an executive MBA from Indiana University’s Kelley School of Business and a Bachelor of Science in mechanical engineering from École Polytechnique de Montréal.
Integer yesterday announced that third-quarter sales increased 8% year over year to $468 million. Adjusted EPS were up 25%. Dziedzic said: “While select headwinds are expected to impact our 2026 sales, we believe our strategy and strong product development pipeline will lead to a return to 200 basis points above-market organic growth in 2027.”
